Skip to content
VietVance

Site search

Science & Technology

Quantum Computing Could Reshape Israel’s Drug Development Landscape

Israeli scholar David Adler says quantum computing could erode Israeli companies’ computational advantage in AI-driven drug development if it makes molecular simulation more accurate, faster and more accessible. Israel’s Classiq and Japan’s Shionogi have begun related research, but quantum computing has yet to demonstrate a direct advantage in discovering new drugs.

VietVance

1 min read

Advances in quantum computing could change the competitive landscape in drug development. Israeli scholar David Adler says that if molecular simulation becomes more accurate, faster and more accessible, the advantage Israeli companies have built through their computing capabilities could narrow. However, quantum computing has yet to consistently demonstrate a practical advantage in drug development.

Illustration related to quantum computing technology.(VietVance)

A 2025–2026 life sciences industry report published by the Israel Advanced Technology Industries association and the Israel Innovation Authority says about 30 companies in the country operate at the intersection of artificial intelligence and drug development. AI and conventional computers are currently used to predict molecular properties, assess interactions between molecules and biological targets, and identify promising compounds for testing.

Because electron behavior and chemical bonds are highly complex, current methods still struggle to calculate some molecular interactions accurately. David Adler says future quantum computers may handle such problems more effectively and improve some stages of compound evaluation and optimization in drug development, though this potential remains to be verified.

Work in this area is already underway. On November 17, Israeli quantum software company Classiq and Japanese pharmaceutical company Shionogi announced that they were using quantum algorithms to study molecular interactions relevant to drug development. The research used simulations and tests on actual quantum computer hardware, but has yet to demonstrate a direct advantage for quantum computing in discovering new drugs. Intel reached an agreement to acquire Classiq in October 2026.

David Adler says countries with large biotechnology industries, ample research and development funding, and testing facilities may eventually combine quantum technology with their existing resources, narrowing the gap with Israel. He recommends that Israel investigate whether quantum technology can improve current computing methods and prepare biotechnology companies to adopt new technologies.

Source: VietVance

Related